“Toll-like receptor”的意思、由来-开放百科全书

TLR's received their name from their similarity to the protein coded by the toll gene identified in Drosophila in 1985 by Christiane Nüsslein-Volhard and Eric Wieschaus.^[2]

Function

The ability of immune system to recognize molecules that are broadly shared by pathogens is, in part, due to the presence of Immune receptors called toll-like receptors (TLRs) that are expressed on the membranes of leukocytes including dendritic cells, macrophages, natural killer cells, cells of the adaptive immunity (T and B lymphocytes) and non immune cells (epithelial and endothelial cells, and fibroblasts).^[3]

The binding of ligands - either in the form of adjuvant used in vaccinations or in the form of invasive moieties during times of natural infection - to the TLR marks the key molecular events that ultimately lead to innate immune responses and the development of antigen-specific acquired immunity.^[4]^[5]

Upon activation, TLRs recruit adapter proteins (proteins that mediate other protein-protein interactions) within the cytosol of the immune cell in order to propagate the antigen-induced signal transduction pathway. These recruited proteins are then responsible for the subsequent activation of other downstream proteins, including protein kinases (IKKi, IRAK1, IRAK4, and TBK1) that further amplify the signal and ultimately lead to the upregulation or suppression of genes that orchestrate inflammatory responses and other transcriptional events. Some of these events lead to cytokine production, proliferation, and survival, while others lead to greater adaptive immunity.^[5] If the ligand is a bacterial factor, the pathogen might be phagocytosed and digested, and its antigens presented to CD4+ T cells.

In the case of a viral factor, the infected cell may shut off its protein synthesis and may undergo programmed cell death (apoptosis). Immune cells that have detected a virus may also release anti-viral factors such as interferons.

Toll-like receptors have also been shown to be an important link between innate and adaptive immunity through their presence in dendritic cells.^[6] Flagellin, a TLR5 ligand induces cytokine secretion on interacting with TLR5 on human T cells.^[6]

Superfamily

TLRs are a type of pattern recognition receptor (PRR) and recognize molecules that are broadly shared by pathogens but distinguishable from host molecules, collectively referred to as pathogen-associated molecular patterns (PAMPs). TLRs together with the Interleukin-1 receptors form a receptor superfamily, known as the "interleukin-1 receptor / toll-like receptor superfamily"; all members of this family have in common a so-called TIR (toll-IL-1 receptor) domain.

Three subgroups of TIR domains exist. Proteins with subgroup 1 TIR domains are receptors for interleukins that are produced by macrophages, monocytes, and dendritic cells and all have extracellular Immunoglobulin (Ig) domains. Proteins with subgroup 2 TIR domains are classical TLRs, and bind directly or indirectly to molecules of microbial origin. A third subgroup of proteins containing TIR domains consists of adaptor proteins that are exclusively cytosolic and mediate signaling from proteins of subgroups 1 and 2.

Extended family

TLRs are present in vertebrates, as well as in invertebrates. Molecular building blocks of the TLRs are represented in bacteria and in plants, and plant pattern recognition receptors are well known to be required for host defence against infection. The TLRs thus appear to be one of the most ancient, conserved components of the immune system.

In recent years TLRs were identified also in the mammalian nervous system. Members of the TLR family were detected on glia, neurons and on neural progenitor cells in which they regulate cell-fate decision.^[7]

It has been estimated that most mammalian species have between ten and fifteen types of toll-like receptors. Thirteen TLRs (named simply TLR1 to TLR13) have been identified in humans and mice together, and equivalent forms of many of these have been found in other mammalian species.^[8]^[9]^[10] However, equivalents of certain TLR found in humans are not present in all mammals. For example, a gene coding for a protein analogous to TLR10 in humans is present in mice, but appears to have been damaged at some point in the past by a retrovirus. On the other hand, mice express TLRs 11, 12, and 13, none of which is represented in humans. Other mammals may express TLRs that are not found in humans. Other non-mammalian species may have TLRs distinct from mammals, as demonstrated by TLR14, which is found in the Takifugu pufferfish.^[11] This may complicate the process of using experimental animals as models of human innate immunity.

TLRs in Drosophila immunity

TLR2

TLR3

TLR11

As noted above, human cells do not express TLR11, but mice cells do. Mouse-specific TLR11 recognizes uropathogenic E.coli and the apicomplexan parasite Toxoplasma gondii. With Toxoplasma its ligand is the protein profilin, but the ligand for E. coli is still not known. Recently the enteropathogen Salmonella spp. was found to have a ligand which is bound by TLR11. Salmonella is a gram-negative flagellated bacterium which causes food- and waterborne gastroenteritis and typhoid fever in humans. TLR11 in mouse intestine recognizes the flagellun protein flagellin, causing dimerization of the receptor, activation of NF-κB and production of inflammatory cytokines. TLR11 deficient mice (knockout mouse) are efficiently infected with orally administered Salmonella Typhi. S. Typhi does not normally infect mice, it is human obligatory pathogen that causes typhoid fever, which affects more than 20 million people and causes more than 220 thousand deaths per year. Because of this, studies were carried out and it was found that tlr-/- mice can be immunized against S. Typhi and they are used as an animal model for studying immune responses against this pathogen and for the development of vaccines, that could be possibly used in the future.^[14]

Summary of known mammalian TLRs

Toll-like receptors bind and become activated by different ligands, which, in turn, are located on different types of organisms or structures. They also have different adapters to respond to activation and are located sometimes at the cell surface and sometimes to internal cell compartments. Furthermore, they are expressed by different types of leucocytes or other cell types:

Ligands

Because of the specificity of toll-like receptors (and other innate immune receptors) they cannot easily be changed in the course of evolution, these receptors recognize molecules that are constantly associated with threats (i.e., pathogen or cell stress) and are highly specific to these threats (i.e., cannot be mistaken for self molecules that are normally expressed under physiological conditions). Pathogen-associated molecules that meet this requirement are thought to be critical to the pathogen's function and difficult to change through mutation; they are said to be evolutionarily conserved. Somewhat conserved features in pathogens include bacterial cell-surface lipopolysaccharides (LPS), lipoproteins, lipopeptides, and lipoarabinomannan; proteins such as flagellin from bacterial flagella; double-stranded RNA of viruses; or the unmethylated CpG islands of bacterial and viral DNA; and also of the CpG islands found in the promoters of eukaryotic DNA; as well as certain other RNA and DNA molecules. For most of the TLRs, ligand recognition specificity has now been established by gene targeting (also known as "gene knockout"): a technique by which individual genes may be selectively deleted in mice.^[32]^[33] See the table below for a summary of known TLR ligands.

Endogenous ligands

The stereotypic inflammatory response provoked by toll Like-Receptor activation has prompted speculation that endogenous activators of toll-like receptors might participate in autoimmune diseases. TLRs have been suspected of binding to host molecules including fibrinogen (involved in blood clotting), heat shock proteins (HSPs), HMGB1, extracellular matrix components and self DNA (it is normally degraded by nucleases, but under inflammatory and autoimmune conditions it can form a complex with endogenous proteins, become resistant to these nucleases and gain access to endosomal TLRs as TLR7 or TLR9). These endogenous ligands are usually produced as a result of non-physiological cell death.^[43]

Signaling

TLRs are believed to function as dimers. Though most TLRs appear to function as homodimers, TLR2 forms heterodimers with TLR1 or TLR6, each dimer having a different ligand specificity. TLRs may also depend on other co-receptors for full ligand sensitivity, such as in the case of TLR4's recognition of LPS, which requires MD-2. CD14 and LPS-Binding Protein (LBP) are known to facilitate the presentation of LPS to MD-2.

A set of endosomal TLRs comprising TLR3, TLR7, TLR8 and TLR9 recognize nucleic acid derived from viruses as well as endogenous nucleic acids in context of pathogenic events. Activation of these receptor leads to production of inflammatory cytokines as well as type I interferons (interferon type I) to help fight viral infection.

The adapter proteins and kinases that mediate TLR signaling have also been targeted. In addition, random germline mutagenesis with ENU has been used to decipher the TLR signaling pathways. When activated, TLRs recruit adapter molecules within the cytoplasm of cells in order to propagate a signal. Four adapter molecules are known to be involved in signaling. These proteins are known as MyD88, Tirap (also called Mal), Trif, and Tram (TRIF-related adaptor molecule).^[35]^[36]^[37]

TLR signaling is divided into two distinct signaling pathways, the MyD88-dependent and TRIF-dependent pathway.

MyD88-dependent pathway

The MyD88-dependent response occurs on dimerization of the TLR receptor, and is utilized by every TLR except TLR3. Its primary effect is activation of NFκB and Mitogen-activated protein kinase. Ligand binding and conformational change that occurs in the receptor recruits the adaptor protein MyD88, a member of the TIR family. MyD88 then recruits IRAK4, IRAK1 and IRAK2. IRAK kinases then phosphorylate and activate the protein TRAF6, which in turn polyubiquinates the protein TAK1, as well as itself in order to facilitate binding to IKK-β. On binding, TAK1 phosphorylates IKK-β, which then phosphorylates IκB causing its degradation and allowing NFκB to diffuse into the cell nucleus and activate transcription and consequent induction of inflammatory cytokines.^[38]

TRIF-dependent pathway

Both TLR3 and TLR4 utilize the TRIF-dependent pathway, which is triggered by dsRNA and LPS, respectively. For TLR3, dsRNA leads to activation of the receptor, recruiting the adaptor TRIF. TRIF activates the kinases TBK1 and RIPK1, which creates a branch in the signaling pathway. The TRIF/TBK1 signaling complex phosphorylates IRF3 allowing its translocation into the nucleus and production of Interferon type I. Meanwhile, activation of RIPK1 causes the polyubiquitination and activation of TAK1 and NFκB transcription in the same manner as the MyD88-dependent pathway.^[38]

TLR signaling ultimately leads to the induction or suppression of genes that orchestrate the inflammatory response. In all, thousands of genes are activated by TLR signaling, and collectively, the TLRs constitute one of the most pleiotropic yet tightly regulated gateways for gene modulation.

TLR4 is the only TLR that uses all four adaptors. Complex consisting of TLR4, MD2 and LPS recruits TIR domain-containing adaptors TIRAP and MyD88 and thus initiates activation of NFκB (early phase) and MAPK. TLR4-MD2-LPS complex then undergoes endocytosis and in endosome it forms a signalling complex with TRAM and TRIF adaptors. This TRIF-dependent pathway again leads to IRF3 activation and production of type I interferons, but it also activates late-phase NFκB activation. Both late and early phase activation of NFκB is required for production of inflammatory cytokines.^[38]

Medical relevance

Imiquimod (cardinally used in dermatology) is a TLR7 agonist, and its successor resiquimod, is a TLR7 and TLR8 agonist.^[39] Recently, resiquimod has been explored as an agent for cancer immunotherapy,^[40] acting through stimulation of tumor-associated macrophages.

The lipid A analogon eritoran acts as a TLR4 antagonist. {{as of|2009|12}}, it is being developed as a drug against severe sepsis.^[41]

As of 2016 several TLR ligands were in clinical development or being tested in animal models as potential vaccine adjuvants.^[42]

Discovery

When microbes were first recognized as the cause of infectious diseases, it was immediately clear that multicellular organisms must be capable of recognizing them when infected and, hence, capable of recognizing molecules unique to microbes. A large body of literature, spanning most of the last century, attests to the search for the key molecules and their receptors. More than 100 years ago, Richard Pfeiffer, a student of Robert Koch, coined the term "endotoxin" to describe a substance produced by Gram-negative bacteria that could provoke fever and shock in experimental animals. In the decades that followed, endotoxin was chemically characterized and identified as a lipopolysaccharide (LPS) produced by most Gram-negative bacteria. This lipopolysaccharide is an integral part of the gram-negative membrane and is released upon destruction of the bacterium. Other molecules (bacterial lipopeptides, flagellin, and unmethylated DNA) were shown in turn to provoke host responses that are normally protective. However, these responses can be detrimental if they are excessively prolonged or intense. It followed logically that there must be receptors for such molecules, capable of alerting the host to the presence of infection, but these remained elusive for many years.

Toll-like receptors are now counted among the key molecules that alert the immune system to the presence of microbial infections. They are named for their similarity to toll, a receptor first identified in the fruit fly Drosophila melanogaster, and originally known for its developmental function in that organism. In 1996, toll was found by Jules A. Hoffmann and his colleagues to have an essential role in the fly's immunity to fungal infection,^[43] which it achieved by activating the synthesis of antimicrobial peptides. The plant homologs were discovered by Pamela Ronald in 1995 (rice XA21)^[44] and Thomas Boller in 2000 (Arabidopsis FLS2).^[45]

The first reported human toll-like receptor was described by Nomura and colleagues in 1994,^[46] mapped to a chromosome by Taguchi and colleagues in 1996.^[47] Because the immune function of toll in Drosophila was not then known, it was assumed that TIL (now known as TLR1) might participate in mammalian development. However, in 1991 (prior to the discovery of TIL) it was observed that a molecule with a clear role in immune function in mammals, the interleukin-1 (IL-1) receptor, also had homology to drosophila toll; the cytoplasmic portions of both molecules were similar.^[48]

In 1997, Charles Janeway and Ruslan Medzhitov showed that a toll-like receptor now known as TLR4 could, when artificially ligated using antibodies, induce the activation of certain genes necessary for initiating an adaptive immune response.^[49] TLR 4 function as an LPS sensing receptor was discovered by Bruce A. Beutler and colleagues.^[50] These workers used positional cloning to prove that mice that could not respond to LPS had mutations that abolished the function of TLR4. This identified TLR4 as one of the key components of the receptor for LPS.

In turn, the other TLR genes were ablated in mice by gene targeting, largely in the laboratory of Shizuo Akira and colleagues. Each TLR is now believed to detect a discrete collection of molecules – some of microbial origin, and some products of cell damage – and to signal the presence of infections.

In 2011, Beutler and Hoffmann were awarded the Nobel Prize in Medicine or Physiology for their work.^[51] Hoffmann and Akira received the Canada Gairdner International Award in 2011.^[52]

Notes and references

1. ^{{cite journal|last1=Mahla|first1=RS|title=Sweeten PAMPs: Role of Sugar Complexed PAMPs in Innate Immunity and Vaccine Biology.|journal=Front Immunol |date=2 September 2013 |page=248|doi=10.3389/fimmu.2013.00248|pmid=24032031|volume=4|pmc=3759294}}
2. ^{{cite journal |vauthors=Hansson GK, Edfeldt K |title=Toll to be paid at the gateway to the vessel wall |journal=Arterioscler. Thromb. Vasc. Biol. |volume=25 |issue=6 |pages=1085–7 |year=2005 |pmid=15923538 |doi=10.1161/01.ATV.0000168894.43759.47 |url=http://atvb.ahajournals.org/cgi/content/full/25/6/1085}}
3. ^{{cite journal |vauthors=Delneste Y, Beauvillain C, Jeannin P |title=Innate immunity: structure and function of TLRs |journal=Med Sci (Paris) |volume=23 |issue=1 |pages=67–73 |year=2007 |pmid=17212934 |doi=10.1051/medsci/200723167}}
4. ^{{cite journal | doi = 10.1093/intimm/dxh186 | last1 = Takeda | first1 = Kiyoshi | last2 = Akira | first2 = Shizuo | year = 2005 | title = Toll-like receptors in innate immunity | url = | journal = International Immunology | volume = 17 | issue = 1| pages = 1–14 | pmid = 15585605 }}
5. ^¹{{cite journal |vauthors=Medzhitov R, Preston-Hurlburt P, Janeway C |title=A human homologue of the Drosophila Toll protein signals activation of adaptive immunity |journal=Nature |volume=388 |issue=6640 |pages=394–7 |year=1997 |pmid=9237759 |doi=10.1038/41131}}
6. ^¹{{cite journal |author=Sharma, N|title=Sphingosine-1-phosphate suppresses TLR-induced CXCL8 secretion from human T cells. |journal=J Leukoc Biol |volume=93|issue=4 |pages=521–528 |year=2013|pmid=23345392 |doi=10.1189/jlb.0712328|display-authors=etal}}
7. ^{{cite journal | pmid = 17704767 | doi=10.1038/ncb1629 | volume=9 | issue=9 | title=Toll-like receptors modulate adult hippocampal neurogenesis |date=September 2007 | pages=1081–8 |author1=Rolls A. |author2=Shechter R. |author3=London A. | journal=Nat. Cell Biol.|display-authors=etal}}
8. ^{{cite journal |vauthors=Du X, Poltorak A, Wei Y, Beutler B |title=Three novel mammalian toll-like receptors: gene structure, expression, and evolution |journal=Eur. Cytokine Netw. |volume=11 |issue=3 |pages=362–71 |date=September 2000 |pmid=11022119 |doi= |url=http://www.john-libbey-eurotext.fr/medline.md?issn=1148-5493&vol=11&iss=3&page=362}}
9. ^{{cite journal |vauthors=Chuang TH, Ulevitch RJ |title=Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9 |journal=Eur. Cytokine Netw. |volume=11 |issue=3 |pages=372–8 |date=September 2000 |pmid=11022120 |doi= |url=http://www.john-libbey-eurotext.fr/medline.md?issn=1148-5493&vol=11&iss=3&page=372}}
10. ^{{cite journal |vauthors=Tabeta K, Georgel P, Janssen E |display-authors=etal |title=Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=101 |issue=10 |pages=3516–21 |date=March 2004 |pmid=14993594 |pmc=373494 |doi=10.1073/pnas.0400525101 |url=http://www.pnas.org/cgi/pmidlookup?view=long&pmid=14993594|bibcode = 2004PNAS..101.3516T}}
11. ^{{cite journal |title=The evolution of vertebrate Toll-like receptors |journal=Proc Natl Acad Sci USA |year=2005 |volume=102 |issue=27 |pages=9577–9582 |pmid=15976025 |url=http://www.pnas.org/content/102/27/9577.full.pdf |doi=10.1073/pnas.0502272102 |vauthors=Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, Smith KD, Hood LE, Aderem A |pmc=1172252|bibcode = 2005PNAS..102.9577R }}
12. ^{{cite journal |vauthors=Ferrandon D, Imler JL, Hetru C, Hoffmann JA | year = 2007 | title = The Drosophila systemic immune response: sensing and signalling during bacterial and fungal infections | url = https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=17948019 | journal = Nat Rev Immunol | volume = 7 | issue = 11| pages = 862–74 | doi = 10.1038/nri2194 | pmid = 17948019 }}
13. ^{{cite journal |author1=Lee J |author2=Sayed N |author3=Hunter A |author4=Au KF |author5=Wong WH |author6=Mocarski ES | year = 2012 | title = Activation of innate immunity is required for efficient nuclear reprogramming | url = https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=23101625 | journal = Cell | volume = 151 | issue = 3| pages = 547–58 | doi = 10.1016/j.cell.2012.09.034 | pmid = 23101625 |display-authors=etal | pmc=3506423}}
14. ^{{cite journal |author1=Mathur R |author2=Oh H |author3=Zhang D |author4=Park SG |author5=Seo J |author6=Koblansky A | year = 2012 | title = A mouse model of Salmonella typhi infection | journal = Cell | volume = 151 | issue = 3| pages = 590–602 | doi = 10.1016/j.cell.2012.08.042 | pmid = 23101627 | pmc=3500584|display-authors=etal}}
15. ^¹²Unless else specified in boxes then ref is: {{cite book |vauthors=Waltenbaugh C, Doan T, Melvold R, Viselli S |series=Lippincott's Illustrated reviews | title=Immunology |publisher=Wolters Kluwer Health/Lippincott Williams & Wilkins |location=Philadelphia |year=2008 |pages=17 |isbn=0-7817-9543-5 |oclc= |doi=}}
16. ^¹{{cite journal|last=Sabroe|first=Ian|author2=Dower SK |author3=Whyte MKB |title=The Role of Toll-Like Receptors in the Regulation of Neutrophil Migration, Activation, and Apoptosis|journal=Clinical Infectious Diseases|year=2005|volume=41 Suppl 7|pages=S421–426|doi=10.1086/431992|pmid=16237641}}
17. ^¹²³{{cite journal |vauthors=Sallusto F, Lanzavecchia A |title = The instructive role of dendritic cells on T-cell responses|journal = Arthritis Res.|volume = 4 Suppl 3|issue = |pages = S127–32|year = 2002|pmid = 12110131|doi = 10.1186/ar567|url = http://www.arthritis-research.com/content/4/S3/S127|pmc = 3240143}}
18. ^{{cite journal|last=Gerondakis|first=Steve|author2=Grumont RJ |author3=Banerjee A |title=Regulating B-cell activation and survival in response to TLR signals|journal=Immunology and Cell Biology|year=2007|volume=85|pages=471–475|doi=10.1038/sj.icb.7100097|pmid=17637697|issue=6}}
19. ^{{cite journal|last=Cario|first=Elke|author2=Rosenberg SL |author3=Brandwein SL |author4=Beck PL |author5=Reinecker HC |author6=Podolsky DK |title=Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors|journal=J. Immunol.|year=2000|volume=164|pages=966–972|doi=10.4049/jimmunol.164.2.966 |pmid= 10623846|issue=2}}
20. ^{{cite journal | pmid = 28965571 | doi=10.1016/j.jtemb.2017.07.006 | volume=44 | title=Ni(II) interaction with a peptide model of the human TLR4 ectodomain | year=2017 | journal=J Trace Elem Med Biol. | pages=151–160 |vauthors=Peana M, Zdyb K, Medici S, Pelucelli A, Simula G, Gumienna-Kontecka E, Zoroddu MA }}
21. ^{{cite journal | pmid = 24861338 | doi=10.1159/000362367 | volume=6 | title=Toxoplasma gondii- derived profilin triggers human toll-like receptor 5-dependent cytokine production | pmc=4141014 | year=2014 | journal=J Innate Immun | pages=685–94 |vauthors=Salazar Gonzalez RM, Shehata H, O'Connell MJ, Yang Y, Moreno-Fernandez ME, Chougnet CA, Aliberti J }}
22. ^Guan,Y.,D.R.Ranoa,S.Jiang,S.K.Mutha,X.Li,J.Baudry,andR.I.Tapping. 2010. Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling. J. Immunol. 184: 5094–5103.
23. ^Chuang, T., and R. J. Ulevitch. 2001. Identification of hTLR10: a novel humanToll-like receptor preferentially expressed in immune cells. Biochim. Biophys.Acta 1518: 157–161
24. ^Hornung, V., S. Rothenfusser, S. Britsch, A. Krug, B. Jahrsdo ̈rfer, T. Giese,S. Endres, and G. Hartmann. 2002. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168: 4531–4537.
25. ^¹Regan, T., K. Nally, R. Carmody, A. Houston, F. Shanahan, J. Macsharry, and E. Brint. 2013. Identification of TLR10 as a key mediator of the inflammatory response to Listeria monocytogenes in intestinal epithelial cells and macro- phages. J. Immunol. 191: 6084–6092.
26. ^{{cite journal|title=TLR11 activation of dendritic cells by a protozoan profilin-like protein|journal=Science |year=2005 |pmid=15860593 |vauthors=Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, Hayden MS, Hieny S, Sutterwala FS, Flavell RA, Ghosh S, Sher A |doi=10.1126/science.1109893 |volume=308 |issue=5728 |pages=1626–9|bibcode=2005Sci...308.1626Y }}
27. ^Pifer R, Benson A, Sturge CR and Yarovinsky F (November 2010). "UNC93B1 is essential for TLR11 activation and IL-12 dependent host resistance to Toxoplasma Gondii". Journal of Biological Chemistry. {{doi|10.1074/jbc.M110.171025}} {{PMID|21097503}}
28. ^{{cite journal|title=Recognition of Profilin by Toll-like Receptor 12 Is Critical for Host Resistance to Toxoplasma gondii |journal=Immunity|year=2012 |pmid=23246311|doi=10.1016/j.immuni.2012.09.016|vauthors=Koblansky AA, Jankovic D, Oh H, Hieny S, Sungnak W, Mathur R, Hayden MS, Akira S, Sher A, Ghosh S |volume=38|issue=1|pages=119–30|pmc=3601573}}
29. ^{{cite journal|title=Expression and distribution of Toll-like receptors 11-13 in the brain during murine neurocysticercosis |journal=Journal of Neuroinflammation |year=2008 |volume=5 |issue= |pmid=19077284 |page=53 |doi=10.1186/1742-2094-5-53 |vauthors=Mishra BB, Gundra UM, Teale JM | pmc=2631477}}
30. ^{{cite journal | pmid = 21131352 | doi=10.1074/jbc.M110.159590 | volume=286 | issue=6 | title=A novel Toll-like receptor that recognizes vesicular stomatitis virus | journal=Journal of Biological Chemistry |date=February 2011 | pages=4517–24 |vauthors=Shi Z, Cai Z, Sanchez A, etal | pmc=3039399}}
31. ^{{cite journal | pmid = 22821982 | doi=10.1126/science.1220363 | volume=337 | issue=6098 | title=TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification | journal=Science |date=August 2012 | pages=1111–5 | vauthors=Oldenburg M, Kruger A, Ferstl R |display-authors=etal|bibcode = 2012Sci...337.1111O}}
32. ^{{cite journal |vauthors=Hoebe K, Du X, Georgel P |display-authors=etal |title=Identification of Lps2 as a key transducer of MyD88-independent TIR signalling |journal=Nature |volume=424 |issue=6950 |pages=743–8 |date=August 2003 |pmid=12872135 |doi=10.1038/nature01889|bibcode = 2003Natur.424..743H}}
33. ^{{cite journal |vauthors=Hemmi H, Takeuchi O, Kawai T, etal |title=A Toll-like receptor recognizes bacterial DNA |journal=Nature |volume=408 |issue=6813 |pages=740–5 |date=December 2000 |pmid=11130078 |doi=10.1038/35047123}}
34. ^http://www.jleukbio.org/content/94/6/1231{{Dead link|date=September 2018 |bot=InternetArchiveBot |fix-attempted=yes }}
35. ^{{cite journal |vauthors=Shigeoka AA, Holscher TD, King AJ, etal |title=TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways |journal=J. Immunol. |volume=178 |issue=10 |pages=6252–8 |date=May 2007 |pmid=17475853 |doi= 10.4049/jimmunol.178.10.6252|url=http://www.jimmunol.org/cgi/pmidlookup?view=long&pmid=17475853}}
36. ^{{cite journal |vauthors=Yamamoto M, Sato S, Hemmi H, etal |title=TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway |journal=Nat. Immunol. |volume=4 |issue=11 |pages=1144–50 |date=November 2003 |pmid=14556004 |doi=10.1038/ni986}}
37. ^{{cite journal |vauthors=Yamamoto M, Sato S, Hemmi H |display-authors=etal |title=Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4 |journal=Nature |volume=420 |issue=6913 |pages=324–9 |date=November 2002 |pmid=12447441 |doi=10.1038/nature01182|bibcode = 2002Natur.420..324Y}}
38. ^¹²³{{cite journal|last=Kawai|first=Taro|author2=Shizuo Akira |title=The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors|journal=Nature Immunology|date=20 April 2010|volume=11|issue=5|doi=10.1038/ni.1863|pages=373–384}}
39. ^{{cite book |author=Peter Fritsch |title=Dermatologie Venerologie : Grundlagen. Klinik. Atlas. |publisher=Springer |location=Berlin |year=2004 | language=German |pages= |isbn=3-540-00332-0 |oclc= |doi= |accessdate=}}
40. ^{{Cite journal|last=Rodell|first=Christopher B.|last2=Arlauckas|first2=Sean P.|last3=Cuccarese|first3=Michael F.|last4=Garris|first4=Christopher S.|last5=Li|first5=Ran|last6=Ahmed|first6=Maaz S.|last7=Kohler|first7=Rainer H.|last8=Pittet|first8=Mikael J.|last9=Weissleder|first9=Ralph|date=2018-05-21|title=TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy|url=https://www.nature.com/articles/s41551-018-0236-8|journal=Nature Biomedical Engineering|language=En|doi=10.1038/s41551-018-0236-8|issn=2157-846X}}
41. ^{{cite journal|pmid=19661804|year=2010|last1=Tidswell|first1=M|last2=Tillis|first2=W|last3=Larosa|first3=SP|last4=Lynn|first4=M|last5=Wittek|first5=AE|last6=Kao|first6=R|last7=Wheeler|first7=J|last8=Gogate|first8=J|last9=Opal|first9=SM|last10=Eritoran Sepsis Study|first10=Group|title=Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis|volume=38|issue=1|pages=72–83|doi=10.1097/CCM.0b013e3181b07b78|journal=Critical Care Medicine|display-authors=8}}
42. ^Toussi DN, Massari P Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands. Vaccines (Basel). 2014 Apr 25;2(2):323-53. {{PMID|26344622}} [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494261/ PMC 4494261/]
43. ^{{cite journal |vauthors=Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA |title=The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults |journal=Cell |volume=86 |issue=6 |pages=973–83 |date=September 1996 |pmid=8808632 |doi= 10.1016/S0092-8674(00)80172-5|url=http://linkinghub.elsevier.com/retrieve/pii/S0092-8674(00)80172-5}}
44. ^{{cite journal | author = Song, W.Y.| title = A receptor kinase-like protein encoded by the rice disease resistance gene, XA21 |journal = Science | volume = 270 | issue = 5243 | pages = 1804–1806| year = 1995 | pmid = 8525370| doi = 10.1126/science.270.5243.1804|bibcode = 1995Sci...270.1804S | last2 = Wang | first2 = G.-L. | last3 = Chen | first3 = L.-L. | last4 = Kim | first4 = H.-S. | last5 = Pi | first5 = L.-Y. | last6 = Holsten | first6 = T. | last7 = Gardner | first7 = J. | last8 = Wang | first8 = B. | last9 = Zhai | first9 = W.-X. | last10 = Zhu | first10 = L.-H. | last11 = Fauquet | first11 = C. | last12 = Ronald | first12 = P. |display-authors=etal}}
45. ^{{cite journal | author = Gomez-Gomez, L.| title = FLS2: an LRR receptor-like kinase involved in the perception of the bacterial elicitor flagellin in Arabidopsis |journal = Molecular Cell | volume = 5 | issue = 6 | pages = 1003–1011| year = 2000 | pmid = 10911994| doi = 10.1016/S1097-2765(00)80265-8| last2 = Boller | first2 = Thomas |display-authors=etal}}
46. ^{{cite journal |vauthors=Nomura N, Miyajima N, Sazuka T, etal |title=Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1 |journal=DNA Res. |volume=1 |issue=1 |pages=27–35 |year=1994 |pmid=7584026 |doi= 10.1093/dnares/1.1.27|url=http://dnaresearch.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=7584026 |format= – ^{[https://scholar.google.co.uk/scholar?hl=en&lr=&q=intitle%3APrediction+of+the+coding+sequences+of+unidentified+human+genes.+I.+The+coding+sequences+of+40+new+genes+%28KIAA0001-KIAA0040%29+deduced+by+analysis+of+randomly+sampled+cDNA+clones+from+human+immature+myeloid+cell+line+KG-1&as_publication=DNA+Res.&as_ylo=1994&as_yhi=1994&btnG=Search Scholar search]}}} {{dead link|date=April 2009}}
47. ^{{cite journal |vauthors=Taguchi T, Mitcham JL, Dower SK, Sims JE, Testa JR |title=Chromosomal localization of TIL, a gene encoding a protein related to the Drosophila transmembrane receptor Toll, to human chromosome 4p14 |journal=Genomics |volume=32 |issue=3 |pages=486–8 |date=March 1996 |pmid=8838819 |doi=10.1006/geno.1996.0150 |url=http://linkinghub.elsevier.com/retrieve/pii/S0888-7543(96)90150-0}}
48. ^{{cite journal |vauthors=Gay NJ, Keith FJ |title=Drosophila Toll and IL-1 receptor |journal=Nature |volume=351 |issue=6325 |pages=355–6 |date=May 1991 |pmid=1851964 |doi=10.1038/351355b0|bibcode = 1991Natur.351..355G }}
49. ^{{cite journal |vauthors=Medzhitov R, Preston-Hurlburt P, Janeway CA |title=A human homologue of the Drosophila Toll protein signals activation of adaptive immunity |journal=Nature |volume=388 |issue=6640 |pages=394–7 |date=July 1997 |pmid=9237759 |doi=10.1038/41131}}
50. ^{{cite journal |vauthors=Poltorak A, He X, Smirnova I|display-authors=etal |title=Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene |journal=Science |volume=282 |issue=5396 |pages=2085–8 |date=December 1998 |pmid=9851930 |doi= 10.1126/science.282.5396.2085|url=http://www.sciencemag.org/cgi/pmidlookup?view=long&pmid=9851930 |bibcode=1998Sci...282.2085P}}
51. ^https://www.nobelprize.org/nobel_prizes/medicine/laureates/2011/press.html
52. ^{{cite news| url=https://www.thestar.com/news/canada/article/958934--b-c-doctor-wins-prestigious-medical-prize?bn=1 | work=The Star | first=Bob | last=Mitchell | title=B.C. doctor wins prestigious medical prize | date=23 March 2011}}